Hendrik Strydom - 09 Nov 2022 Form 3 Insider Report for ASP Isotopes Inc. (ASPI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
14 Nov 2022, 15:47:21 UTC
Next SEC filing
16 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Hendrick Strydom, Ph.D.

Key filing fact

Hendrik Strydom filed Form 3 for ASP Isotopes Inc. (ASPI) on 14 Nov 2022.

Key facts

  • This page summarizes Hendrik Strydom's Form 3 filing for ASP Isotopes Inc. (ASPI).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 14 Nov 2022, 15:47.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPI holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,597,423
Date
09 Nov 2022
Ownership
By Tianne Holdings (Pty) Ltd
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares are owned directly by Tianne Holdings (Pty) Ltd. Dr. Strydom has voting and dispositive power over such shares.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .